Glycolipids presented by the major histocompatibility complex (MHC) class I homolog CD1d are recognized by natural killer T cells (NKT cells) characterized by either a semi-invariant T cell antigen receptor (TCR) repertoire (type I NKT cells or iNKT cells) or a relatively variable TCR repertoire (type II NKT cells). Here we describe the structure of a type II NKT cell TCR in complex with CD1d-lysosulfatide. Both TCR a-chains and TCR b-chains made contact with the CD1d molecule with a diagonal footprint, typical of MHC-TCR interactions, whereas the antigen was recognized exclusively with a single TCR chain, similar to the iNKT cell TCR. Type II NKT cell TCRs, therefore, recognize CD1d-sulfatide complexes by a distinct recognition mechanism characterized by the TCR-binding features of both i NKT cells and conventional peptide-reactive T cells. npg
A r t i c l e s Natural killer T cells (NKT cells) represent one of the most extensively studied unconventional lineages of T lymphocytes 1, 2 . Characterization of this population has provided important insights related to the development and physiological role of innate-like T cells in immunity as well as the range of antigen-recognition mechanisms used by αβ T cell antigen receptors (TCRs). NKT cells reactive to antigens presented by CD1d can be categorized as type I or iNKT cells (which express a semiinvariant TCR characterized in mice by a conserved rearrangement of the α-chain variable region 14 and α-chain joining region 18 (V α 14-J α 18) paired with a limited repertoire of V β chains, mainly V β 8.2, V β 7 and V β 2) and type II NKT cells (which express a more variable TCR repertoire). Lipid antigens bind to the CD1d groove, with their hydrophobic portion occupying the two main groove pockets (A′ and F′) and their polar portion exposed to the solvent 3 . Although the iNKT cell TCR can recognize both α-linked and β-linked glycolipids by forcing the antigens into a conserved conformation [4] [5] [6] [7] , type II NKT cells do not respond to α-linked glycolipids. Crystal structures of iNKT cell TCRs in complex with various CD1d-presented antigens have shown that the semi-invariant TCR docks with an unique mode, parallel to the CD1d antigen-binding groove, with most of the interface dominated by the germline-encoded α-chain 4, 7, 8 . The lack of a universal antigen for type II NKT cells, analogous to the potent iNKT cell TCR ligand α-galactosylceramide (α-GalCer) 9 , has so far hampered understanding of the role of this cell population in normal states as well as in pathological states, despite the fact that type II NKT cells constitute a substantial portion of the CD4 + T cells in mice deficient in major histocompatibility complex (MHC) class II (refs. 10, 11) and in human bone marrow 12 , liver 13 and gut 14 . Nonetheless, type II NKT cells reactive to the widely expressed self antigen sulfatide 15 have been found to be involved in the suppression of tumor immunity 16 , regulation of ischemic reperfusion 17, 18 , experimental autoimmune encephalomyelitis 15 , concanavalin A-induced hepatitis 19 and type 1 diabetes 20 . Notably, the finding that the administration of sulfatide protects mice from inflammatory disease in the central nervous system and liver in a manner dependent on type II NKT cells [15] [16] [17] [18] [19] [20] suggests potential for the development of new agonists able to harness the immunomodulatory potential of this cell population. Sulfatide-reactive type II NKT cells use an oligoclonal repertoire with characteristics of both antigenspecific conventional T cells and innate-like T cells 21 . However, it is not known how these features of type II NKT cell TCRs determine the recognition of self antigen. We report here the crystal structure (at a resolution of 2.1 Å) of a type II NKT cell TCR (V α 1-J α 26 and V β 16-J β 2.1) isolated from the sulfatide-reactive, CD1d-restricted T cell hybridoma Hy19.3 (a subclone of the XV19 hybridoma) 15, 22, 23 , as well as the crystal structure of the ternary complex of the TCR bound to mouse CD1d-lysosulfatide (LSF) at a resolution of 3.5 Å. LSF, which lacks the fatty-acid chain present on most sulfatide molecules, has been identified as the most potent antigen recognized by the Hy19.3 TCR 22,23 , and high concentrations of LSF are found in tissues from people with metachromatic leukodystrophy 24 . The structural and biochemical data presented here describe how type II NKT cells recognize antigens by a distinct recognition mechanism, which provides a rationale for the TCR repertoire used by this population.
RESULTS
The Hy19.3 TCR binds diagonally above the CD1d A′ pocket To investigate the structural basis of the recognition of sulfatide by type II NKT cells, we determined the crystal structure of the mouse A r t i c l e s CD1d-LSF-Hy19.3 TCR complex at a resolution of 3.5 Å ( Fig. 1 and Table 1 ). Two highly similar ternary complexes (r.m.s. deviation of 0.7 Å over Cα atoms) were present in the asymmetric unit, and the following analysis was limited to one complex, unless otherwise stated. The electron density for both CD1d and the TCR at the complex interface was unambiguous ( Supplementary Fig. 1 ). Strong density was present for the galactosyl moiety of LSF, whereas we observed relatively weak density for the sphingosine acyl chain modeled in the F′ pocket and a spacer occupying the A′ pocket (modeled as palmitic acid; Supplementary  Fig. 1) , similarly to what has been observed for the single alkyl-chain ligand lysophosphatidylcholine from the human CD1d-iNKT cell TCR complex 25 . The buried surface area of the CD1d-TCR was ~910 Å 2 , slightly more than that of the iNKT cell TCR (~760 Å 2 ) 8 but below the range of values observed for MHC-TCR complexes (1,200-2,400 Å 2 ) 26 . The Hy19.3 TCR docked on the CD1d antigen-binding groove with an almost perpendicular orientation, roughly centered above the A′ pocket ( Fig. 1a ) with its V α domain contacting the α2 helix (residues 154-167), whereas the V β domain bound to the α1 helix (residues 68-79; Fig. 1b ). This binding orientation was very different from that of the iNKT cell TCR, which bound above the opposite CD1d F′ pocket parallel to the CD1d α-helices 8 (Fig. 1c) . We calculated the docking angle of the Hy19.3 TCR to be 74°, at the high end of the range of docking angles reported for MHC-TCR complexes (21-70°) 26 . Therefore, glycolipid-reactive type I and type II NKT cell TCRs mark the extreme ends of binding orientations of conventional peptide-MHC-reactive TCRs that typically bind diagonally above the antigen-presenting molecule, such as in the complex of the 2C TCR, H-2K b MHC and dEV8 peptide 26, 27 (Fig. 1d) . Notably, the only known TCR with a higher docking angle (84°) is specific for a myelin protein-derived antigen 28 . This TCR also docked above the amino-terminal portion of the peptide corresponding to the A′ pocket ( Supplementary Fig. 2) , and it was proposed that this unusual binding mode allowed escape of negative selection 28 . Overall, the structure of the ternary complex showed that the Hy19.3 TCR docked on CD1d with an almost perpendicular orientation, which resulted in a footprint radically different from that of a previously described iNKT cell TCR.
CDR1 and CDR2 contacts and the type II NKT cell repertoire Both TCR chains made similar contributions to the interface with mouse CD1d in terms of buried surface area (α-chain, 49%; β chain, 51%). In contrast to the contacts made with the iNKT cell TCR, all six complementarity-determining region (CDR) loops contacted the mouse CD1d-LSF complex (Fig. 2) . Specific residues on the germlineencoded CDR1 and CDR2 loops bound mouse CD1d, with CDR1β also contacting the antigen. In particular, residue Tyr33α of CDR1α, together with Phe52α, Ser53α and Asp54α of CDR2α, interacted with the α2 helix and an N-linked oligosaccharide (Asn165, Fig. 2a,b) , whereas Tyr31β on CDR1β and Tyr50β of CDR2β contacted residues on the α1 helix ( Fig. 2e,f) . These loops contacted human and mouse CD1d in correspondence of two 'hot spots' identified before on the MHC protein surface (corresponding to Met69 of the α1 helix and Ala158 on the α2 helix), and two of the three residues equivalent to the 'restriction triad' always contacted by MHC-reactive TCRs 2 were also contacted by the Hy19.3 TCR (His68 and Val72; Supplementary  Table 1 ), which resulted in the diagonal, albeit shifted, docking mode typical of MHC-TCR interactions 29 . Notably, among the mouse V β segments, only V β 16, V β 8.1 and V β 8.3 have the combination of critical residues used to contact mouse CD1d-LSF (His30, Tyr31 and Tyr50), whereas only V α 1, V α 3, V α 5 and V α 8 have the combination of Tyr33 or Phe33 and Tyr52 in contact with the α2 helix. Notably, these represent most V segments identified in type II NKT cells 11 and 
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A r t i c l e s in particular among sulfatide-reactive ones 21 , which suggests a conserved docking mode for type II NKT cell TCRs. Thus, the requirement for specific contacts between the CDR1 and CDR2 loops and the mouse CD1d α1 and α2 helices observed for the Hy19.3 TCR provides an explanation for the TCR repertoire used by type II NKT cells.
Both CDR3a and CDR3b are critical for complex formation The Hy19.3 TCR bound to mouse CD1d-LSF with micromolar affinity, as measured by surface plasmon resonance (Fig. 3a) . The binding was characterized by relatively slow on rates and fast off rates, not dissimilar to what has been reported for interactions between weak iNKT cell antigens and MHC-TCR 30 . As most of the interface contacts in the ternary complex were mediated by the CDR3 loops not encoded by the germline (CDR3α and CDR3β accounted for 34% and 32% of the total buried surface area, respectively), we next determined whether substitution of residues on those two loops affected binding of the TCR. Consistent with the proposal of a pivotal role for the CDR3 loops at the CD1d-TCR interface, substitution of any of
M55β Y50β 
A r t i c l e s the residues at the tip of these two CDR loops with alanine (N96Aα, N97Aα, Y98Aα, F96Aβ, W97Aβ or Y100Aβ) resulted in abrogation of binding, as measured by surface plasmon resonance, whereas the substitution in the control mutant E102Aβ did not have this effect ( Fig. 3b-h) . These results were reminiscent of what has been reported for MHC-reactive TCRs, for which both CDR3 loops have a critical role in complex formation, but was in contrast to results obtained with the iNKT cell TCR, for which CDR3β is thought to modulate only the affinity of the TCR for the CD1d-antigen complex 26, 31 .
Notably, the Hy19.3 TCR CDR3α loop exclusively contacted the mouse CD1d surface (Fig. 2c) , whereas the CDR3β loop contacted both mouse CD1d and the antigen (Fig. 2g) . A Gln95-Asn96-Asn97-Tyr98 motif on CDR3α bound to the top of the A′ roof of mouse CD1d, contacting both helices via polar and van der Waals contacts (Supplementary Table 1 ). The central Asn96-Asn97 motif observed on CDR3α is present on a sizeable proportion of sulfatidereactive type II NKT cell TCRs 21 (Supplementary Fig. 3) . Moreover, the length of the CDR3α of this TCR (ten amino acids) was similar to that of the highly restricted length of this loop in V α 3 and V α 1 sulfatide-reactive TCRs 21 and other type II NKT cells (eight to nine amino acids) 11 . Therefore, both CDR3α and CDR3β had a critical role in the formation of the ternary complex, with the interaction between mouse CD1d and CDR3α resulting in the oligoclonal nature of the CDR3α loops observed in type II NKT cells.
Substitution of the A′ pocket abolishes binding of Hy19.3 TCR Substitution of selected amino-acid residues of mouse CD1d (Fig. 4a) showed that perturbation of the area around the A′ pocket (Phe10Ala, Met69Ala and Met162Ala) resulted in disruption of the mouse CD1d-Hy19.3 TCR interaction, as measured by an antigen-presentation assay (Fig. 4b) . Those substitutions, however, did not substantially affect the binding of the iNKT cell TCR on the opposite side of mouse CD1d 4,7,8 , above the F′ pocket (Fig. 4c) . Notably, substitution of the aspartic acid at position 153 (which is crucial for the binding of iNKT antigens) with alanine or tyrosine resulted in more stimulation of the type II NKT hybridoma (Fig. 4b) , which suggested that this residue was not involved in specific interactions with the antigen but instead impaired TCR recognition. As expected, residues around the F′ pocket were not crucial for the binding of Hy19.3 TCR, except for Leu150. However, as this residue was not near the Hy19.3 TCR, the substitution with alanine probably affected the binding of LSF to mouse CD1d. The presence of polymorphisms at CD1d residue 162 in laboratory and wild-type mouse strains have been shown to substantially affect the recognition of CD1d-antigen complexes by type II NKT cells 32 . In the ternary complex structure described here, the side chain of Met162 was capped by the aromatic residues Tyr33α, Phe52α and Tyr100β ( Supplementary  Fig. 4) , which would provide an explanation for why modifications at this position can have direct consequences on the binding of the TCR. Notably, we also observed some degree of cross-species reactivity between human CD1d molecules and the Hy19.3 TCR, although to a lesser extent than with the iNKT cell TCR (Supplementary Fig. 5 ).
The Hy19.3 TCR recognizes LSF exclusively via the b-chain
The side chain of His29β on CDR1β contacted the sulfate group of LSF, whereas the bulky side chains Phe96β and Trp97β on CDR3β pinned the galactosyl residue against Asp153 on the mouse CD1d α2 helix (Fig. 2h) , which would explain the 'preference' of this TCR for the extended-ligand conformation typical of β-linked glycolipids. This rather nonspecific binding mode suggested that modifications at the 4′ and 6′ positions of the hexose moiety would probably be tolerated. Moreover, comparison of the binding orientation of LSF and the closely related cis-tetracosenoyl sulfatide that we had crystallized bound to mouse CD1d in the absence of any TCR 33 (Supplementary  Fig. 6 ) showed that they had considerable similarity, which further suggested that this TCR was able to bind several CD1d-ligand complexes with a conserved mode of recognition 23 . Notably, LSF was shifted by approximately 3 Å toward the F′ pocket, probably as a result of the presence of the bulky Trp97 of CDR3β ( Supplementary  Fig. 6 ). Furthermore, whereas the 'lyso' isoforms of sulfatide and glucosylceramide were the main antigenic lipids able to stimulate Hy19.3 cells when presented by splenocytes (Fig. 5a) , several dual-alkyl chain β-linked glycolipids, such as various forms of sulfatide (with C 16:0 , C 24:0 and C 24:1 acyl chains) and β-GalCer, were also recognized Figure 4 Substitution of CD1d residues at the interface affects activation of the Hy19.3 hybridoma. (a) Localization of mutant CD1d residues at the mouse CD1d-TCR interface: CD1d (gray surface) is presented with residues of the α-chain (blue) or β-chain (dark red) footprint; magenta indicates the only residue shared by the two footprints (Met162); yellow, LSF. (b,c) Release of IL-2 (a measure of hybridoma activation) by Hy19.3 cells (b) or the iNKT cell hybridoma line Hy1.2 (c) after stimulation in a plate coated with wild-type mouse CD1d (WT) or various mouse CD1d mutants (horizontal axes) loaded with LSF (2 µg/ml; Hy19.3 (b)) or α-GalCer (0.5 µg/ml; Hy1.2 (c)) at an optimal concentration determined by antigen titration. Data are representative of at least five independent experiments (error bars, s.e.m.). (Fig. 5b) . Substitution of Asp153 or Leu150 generally enhanced the antigenicity of most lipids (Fig. 5b) . The lack of antigenicity observed for lysolecithin (lysophospatidylcholine) was probably the result of the considerable difference between the polar moiety (a phosphorylcholine group) of this lipid and that of the other antigens that carry hexose sugars. Moreover, the differences between plate-bound mouse CD1d and antigen-presenting cells in antigen presentation suggested that antigen-presenting cells either process antigens into an inactive form or prevent their presentation at the cell surface, consistent with the reported requirement for the trafficking of mouse CD1d to the lysosomal compartment for activation of type II NKT cells 22, 34 .
Flexibility in the Hy19.3 TCR and binding thermodynamics We also determined the structure of the Hy19.3 TCR alone at a resolution of 2.1 Å ( Table 1 ) and compared it with the structure of the same TCR in the ternary complex. Superposition of the two TCR structures not in complex present in the asymmetric unit onto the TCR conformation observed in the ternary complex showed flexibility in the CDR1α, CDR2β and CDR3 loops ( Fig. 6a) , which would potentially allow the TCR to recognize an even broader spectrum of antigens through fine positioning of the CDR footprint, as has been reported for some MHC-reactive TCRs 2 . That finding was in contrast to results obtained for the iNKT cell TCR, which binds to CD1d-presented antigens without substantial conformational changes in its CDR loops 4, 8 .
Also in contrast to the iNKT cell TCR 35 , we observed that the binding affinity of the Hy19.3 TCR was temperature dependent ( Fig. 6b and Supplementary Fig. 7) . Notably, van't Hoff analysis of the binding data ( Fig. 6c) suggested that the complex formation was driven entropically, possibly as a result of the hydrophobic interactions created at the CD1-TCR interface and/or water displacement (although the low resolution of the ternary complex did not allow us to model water molecules), similar to what has been reported, for example, for the complex of HLA-B8, FLR peptide and the 13 TCR 36 .
DISCUSSION
The mouse CD1d-LSF-Hy19.3 TCR structure reported here has provided insight into the recognition of a lipid antigen by a noninvariant NKT cell TCR. Unexpectedly, the binding mode for the Hy19.3 TCR combined features of both iNKT cells and MHCrestricted T cells, which resulted in a unique antigen-recognition mechanism among αβ TCRs. In the type II NKT ternary complex, both the TCR α-chain and TCR β-chain contact the CD1d molecule with a diagonal footprint, typical of MHC-TCR interactions 26 . For peptide-MHC-reactive T cells, optimal T cell activation occurs when the coreceptor is engaged, which correlates with a limited range of TCR docking angles 37 . However, as NKT cells can be double-negative for expression of the CD4 and CD8 coreceptors 1 , the angle at which the TCR docks on CD1d is not influenced by the engagement of coreceptors; thus, its importance in T cell activation remains unclear. However, the Hy19.3 TCR recognized the antigen exclusively with only one TCR chain, similar to the iNKT cell TCR 4, 8 , whereas MHC-reactive TCRs need both CDR3 loops to contact the antigen 26 . Unlike the iNKT cell TCR, which contacts the ligand with its α-chain, the type II NKT cell TCR bound lysosulfatide solely through the TCR β-chain, which suggested that the latter chain was responsible for the fine antigen specificity of the TCR. Consistent with that, oligoclonal use of V β and variability in the length and sequence of the CDR3β loop have been observed in sulfatide-reactive NKT cells 21 . The role of the CDR1β and His29 in particular seemed less critical, as antigens that lack a sulfate group, such as β-GalCer and 'lyso' isoforms of glucosylceramide, were still recognized by this TCR. The conservation of key CDR1-and CDR2-interacting residues in lysosulfatide-reactive TCR and other sulfatide-reactive TCRs 21 suggests a shared recognition 'logic' for this class of self antigens that could extend to a substantial proportion of type II NKT cells 11 . Moreover, the finding that the CDR3α loop was not directly involved in antigen recognition but instead recognized the CD1d surface provides an explanation for the restricted length and conserved motifs observed on the CDR3α loop of most sulfatidereactive and type II NKT cell TCRs. We hypothesize that rearrangement of the TCR α-chain is not a result of positive selection by a self antigen, as is true for iNKT cells, but is instead driven by binding to the nonpolymorphic CD1d molecule, consistent with the presence of sulfatide-reactive type II NKT cells in mice deficient in sulfatide 15, [21] [22] [23] . Collectively, our data suggest that the immune system developed two very different strategies that enable the 'nonpolymorphic' CD1d to bind at least two different types of NKT cell TCRs. The finding that a substantial proportion of type II NKT cells respond to the myelinderived glycolipid sulfatide 15 has been pivotal in determining the role of these cells in normal processes as well as in pathological processes. Given the growing recognition of the role of sulfatide-reactive type II NKT cells in the suppression of tumor immunity and regulation of autoimmune diseases [15] [16] [17] [18] [19] [20] , with the consequent therapeutic potential, the structure described here opens the way to the rational development of new ligands with immunomodulatory potential. 
